LifeMD $LFMD plunges 40% on earnings miss, guidance cut highlights...
Key Takeaways LifeMD’s shares declined by over 40% following a Q2 earnings report that missed revenue and EPS estimates, coupled with a reduction in full-year guidance. The guidance cut was...